Thursday, December 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Strategy’s Aggressive Bitcoin Acquisition Sparks Investor Concern

Robert Sasse by Robert Sasse
December 9, 2025
in Bitcoin, Crypto Stocks, Mergers & Acquisitions
0
Strategy Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Strategy Inc. has initiated its most significant Bitcoin purchasing spree in six months, acquiring a substantial 10,624 BTC between December 1st and 7th. The nearly $963 million expenditure was funded entirely through equity sales. While the company’s shares responded positively initially, climbing 2.6 percent to $183.69 on Monday, the financing method has raised significant red flags among market analysts.

Equity Sales Fuel Crypto Buying Binge

To finance this massive crypto acquisition, Strategy leveraged capital markets aggressively. The company raised $928 million from the sale of 5.13 million common shares, supplemented by an additional $35 million from preferred stock offerings. The average purchase price for Bitcoin was approximately $90,615 per coin.

This latest buying wave expands Strategy’s holdings to 660,624 BTC, representing over 3.1 percent of Bitcoin’s total possible supply of 21 million coins. The firm’s total cost basis for its entire portfolio stands at $49.35 billion, reflecting an average entry price of $74,696 per Bitcoin. With current prices hovering around $91,000, the company is sitting on an unrealized gain of roughly $11 billion.

Dilution Fears Trigger Analyst Downgrades

The decision to fund the purchase through share issuance is drawing sharp criticism. Analysts have swiftly adjusted their outlooks, citing heightened dilution risks for existing shareholders. TD Cowen reduced its price target from $535 to $500, explicitly pointing to these increasing dilution concerns. Cantor Fitzgerald issued an even more drastic revision, slashing its target from $560 to $229—a staggering 59 percent cut.

Should investors sell immediately? Or is it worth buying Strategy?

Despite a recent partial recovery, Strategy’s stock price remains more than 50 percent below its six-month highs. In a related move just one week prior to the Bitcoin purchase, the company established a $1.44 billion USD reserve. This fund is intended to cover dividend obligations on its preferred shares for a 21-month period, a signal that its cost of capital is rising.

Revised Forecasts and Technical Indicators

The volatile cryptocurrency market has forced Strategy to recalibrate its financial guidance for 2025. Following Bitcoin’s decline from a late-October peak of $111,612 to a November low beneath $81,000, the company revised its projections downward. Details of the updated target range were included in an SEC filing, highlighting Strategy’s ongoing dependence on Bitcoin’s price performance.

Technical indicators further illustrate the stock’s turbulent state. The Relative Strength Index (RSI) currently reads 84.2, signaling a technically overbought condition. Meanwhile, the annualized 30-day volatility sits at 60.66 percent, underscoring the extreme price swings characteristic of the asset. In pre-market trading on Tuesday, shares were quoted at $183.37.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from December 11 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 11.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Standard Lithium Stock
Analysis

Standard Lithium’s Funding Milestone: A Critical Juncture for Arkansas Project

December 11, 2025
Intel Stock
AI & Quantum Computing

Intel’s Strategic Moves Face Market Scrutiny Amid AI Push

December 10, 2025
Tegna Stock
Analysis

Regulatory Scrutiny Casts Doubt on Tegna Acquisition Timeline

December 10, 2025
Next Post
Healwell AI Stock

Healwell AI Shares Struggle to Gain Traction Despite Strong Revenue Growth

XRP Stock

Institutional Capital Pours Into XRP Amid Regulatory Milestones

Vita Coco Company Stock

The Vita Coco Company: Robust Earnings and a Favorable Trade Shift Fuel Rally

Recommended

Cellectar Stock

Cellectar Shares Show Promise Amid Regulatory Advances

1 month ago
Qualcomm Stock

Qualcomm’s Strategic Pivot: Challenging AI Dominance with Billion-Dollar Deal

1 month ago
Ethereum Stock

Ethereum’s Resurgence: Network Strength Meets Institutional Pressure

1 month ago
C3.ai Stock

C3.ai Shares Plunge Amid Mounting Challenges

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

NASA Contract Bolsters Investor Confidence in Plug Power

Gold Nears Record Territory as Central Bank Moves and Demand Converge

Nel ASA Strengthens Project Leadership Amid Strong Order Intake

Ballard Power: A Cautious Market Appraises Operational Gains

XRP Faces a Supply Crunch as Institutional Demand Soars

Standard Lithium’s Funding Milestone: A Critical Juncture for Arkansas Project

Trending

Assembly Biosciences Stock
Analysis

Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades

by Andreas Sommer
December 11, 2025
0

Growing optimism surrounds Assembly Biosciences following the release of compelling interim data from its Phase 1b study...

Nio Stock

Nio Shares Seek a Firmer Foundation After Steep Decline

December 11, 2025
Vulcan Energy Stock

Vulcan Energy Secures Full Funding and Key Site for Lithium Project

December 11, 2025
Plug Power Stock

NASA Contract Bolsters Investor Confidence in Plug Power

December 11, 2025
Gold Stock

Gold Nears Record Territory as Central Bank Moves and Demand Converge

December 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades
  • Nio Shares Seek a Firmer Foundation After Steep Decline
  • Vulcan Energy Secures Full Funding and Key Site for Lithium Project

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com